Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature

Pharmacological Research

Volumn 120, Issue , 2017, Pages 34-42

  Pucci, Giacomo ^a,b   Alcidi, Riccardo ^a,b   Tap, Lisanne ^c   Battista, Francesca ^a,b   Mattace Raso, Francesco ^c   Schillaci, Giuseppe ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Struttura Complessa di Medicina Interna   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular risk; Gender differences; Insulin resistance; Lifestyle treatment; Metabolic syndrome; Sex hormones

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE METABOLISM; HEALTH SERVICE; HEART INFARCTION; HUMAN; HYPERANDROGENISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MENOPAUSE; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREGNANCY DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; COMPLICATION; FEMALE; LIFESTYLE; MALE;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 85016045219     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2017.03.008     Document Type: Review

References (88)

1. [1] Laaksonen, D.E., Lakka, H.M., Niskanen, L.K., Kaplan, G.A., Salonen, J.T., Lakka, T.A., Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156 (2002), 1070–1077.
2. [2] Haffner, S., Taegtmeyer, H., Epidemic obesity and the metabolic syndrome. Circulation 108 (2003), 1541–1545.
3. [3] Beltrán-Sánchez, H., Harhay, M.O., Harhay, M.M., McElligott, S., Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J. Am. Coll. Cardiol. 62 (2013), 697–703.
4. [4] Xi, B., He, D., Hu, Y., Zhou, D., Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev. Med. 57 (2013), 867–871.
5. [5] Vishram, J.K., Borglykke, A., Andreasen, A.H., Jeppesen, J., Ibsen, H., Jørgensen, T., Palmieri, L., Giampaoli, S., Donfrancesco, C., Kee, F., Mancia, G., Cesana, G., Kuulasmaa, K., Salomaa, V., Sans, S., Ferrieres, J., Dallongeville, J., Söderberg, S., Arveiler, D., Wagner, A., Tunstall-Pedoe, H., Drygas, W., Olsen, M.H., MORGAM Project. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project. PLoS One, 9, 2014, e107294.
6. [6] Prasad, D.S., Kabir, Z., Dash, A.K., Das, B.C., Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J. Cardiovasc. Dis. Res. 3 (2012), 204–211.
7. [7] Miller, J.M., Kaylor, M.B., Johannsson, M., Bay, C., Churilla, J.R., Prevalence of metabolic syndrome and individual criterion in US adolescents: 2001–2010 National Health and Nutrition Examination Survey. Metab. Syndr. Relat. Disord. 12 (2014), 527–532.
8. [8] Ford, E.S., Risks for all-cause mortality cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005), 1769–1778.
9. [9] Krieger, N., Genders, sexes, and health: what are the connections-and why does it matter?. Int. J. Epidemiol. 32 (2003), 652–657.
10. [10] Regitz-Zagrosek, V., Oertelt-Prigione, S., Prescott, E., Franconi, F., Gerdts, E., Foryst-Ludwig, A., Maas, A.H., Kautzky-Willer, A., Knappe-Wegner, D., Kintscher, U., Ladwig, K.H., Schenck-Gustafsson, K., Stangl, V., EUGenMed Cardiovascular Clinical Study Group, Gender in cardiovascular diseases: impact on clinical manifestations management, and outcomes. Eur. Heart J. 37 (2016), 24–34.
11. [11] Council of Europe, Committee of Ministers, Recommendation CM⁄Rec(2008)1 of the Committee of Ministers to Member States on the Inclusion of Gender Differences in Health Policy. 2008.
12. [12] Reaven, G.M., Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37 (1988), 1595–1607.
13. [13] Kaplan, N.M., The deadly quartet. Upper-body obesity glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149 (1989), 1514–1520.
14. [14] Jousilahti, P., Vartiainen, E., Tuomilehto, J., Sex, Puska P., age cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99 (1999), 1165–1172.
15. [15] Department of Noncommunicable Disease Surveillance, World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications [Internet]., 1999, WHO Publication, Geneva, 59 Report No. 99.2.
16. [16] Einhorn, D., Reaven, G.M., Cobin, R.H., Ford, E., Ganda, O.P., Handelsman, Y., Hellman, R., Jellinger, P.S., Kendall, D., Krauss, R.M., Neufeld, N.D., Petak, S.M., Rodbard, H.W., Seibel, J.A., Smith, D.A., Wilson, P.W., American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9 (2003), 237–252.
17. [17] Alberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23:82006 (2016), 469–480.
18. [18] Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol In adults (Adult treatment panel III). JAMA 285 (2001), 2486–2497.
19. [19] Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C. Jr, Spertus, J.A., Costa, F., American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005), 2735–2752.
20. [20] Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M., Smith, S.C. Jr, International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
21. [21] Balkau, B., Charles, M.A., Drivsholm, T., Borch-Johnsen, K., Wareham, N., Yudkin, J.S., Morris, R., Zavaroni, I., van Dam, R., Feskins, E., Gabriel, R., Diet, M., Nilsson, P., Hedblad, B., European Group For The Study Of Insulin Resistance (EGIR), Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 28 (2002), 364–376.
22. [22] Regitz-Zagrosek, V., Lehmkuhl, E., Mahmoodzadeh, S., Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend. Med. 4:Suppl. B (2007), S162–S177.
23. [23] Unwin, N., Shaw, J., Zimmet, P., Alberti, K.G., Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med. 19 (2002), 708–723.
24. [24] Park, Y.W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R., Heymsfield, S.B., The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163 (2003), 427–436.
25. [25] Kuk, J.L., Ardern, C.I., Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 33 (2010), 2457–2461.
26. [26] Wang, W.S., Wahlqvist, M.L., Hsu, C.C., Chang, H.Y., Chang, W.C., Chen, C.C., Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health, 12, 2012, 111.
27. [27] Chen, Y.C., Wu, H.P., Hwang, S.J., Li, I.C., Exploring the components of metabolic syndrome with respect to gender difference and its relationship to health-promoting lifestyle behaviour: a study in Taiwanese urban communities. J. Clin. Nurs. 19 (2010), 3031–3041.
28. [28] Song, Q.B., Zhao, Y., Liu, Y.Q., Zhang, J., Xin, S.J., Dong, G.H., Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab. Vasc. Dis. Res. 12 (2015), 189–198.
29. [29] Lee, S., Ko, Y., Kwak, C., Yim, E.S., Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. BMC Geriatr., 16, 2016, 27.
30. [30] Pannier, B., Thomas, F., Eschwège, E., Bean, K., Benetos, A., Leocmach, Y., Danchin, N., Guize, L., Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study. Diabetes Metab. 32 (2006), 467–474.
31. [31] Császár, A., Kékes, E., Abel, T., Papp, R., Kiss, I., Balogh, S., Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Press. 15 (2006), 101–106.
32. [32] Dallongeville, J., Cottel, D., Arveiler, D., Tauber, J.P., Bingham, A., Wagner, A., Fauvel, J., Ferrières, J., Ducimetière, P., Amouyel, P., The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann. Nutr. Metab. 48 (2004), 43–50.
33. [33] Janssen, I., Powell, L.H., Crawford, S., Lasley, B., Sutton-Tyrrell, K., Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch. Intern. Med. 168 (2008), 1568–1575.
34. [34] Gambacciani, M., Ciaponi, M., Cappagli, B., Benussi, C., De Simone, L., Genazzani, A.R., Climacteric modifications in body weight and fat tissue distribution. Climacteric 2 (1999), 37–44.
35. [35] Pradhan, A.D., Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin. Chem. 60 (2014), 44–52.
36. [36] Razzouk, L., Muntner, P., Ethnic gender, and age related differences in patients with the metabolic syndrome. Curr. Hypertens. Rep. 11 (2009), 127–132.
37. [37] Lovejoy, J.C., Champagne, C.M., de Jonge, L., Xie, H., Smith, S.R., Increased visceral fat and decreased energy expenditure during the menopausal transition. Int. J. Obes. (Lond). 32 (2008), 949–958.
38. [38] Barros, R.P., Gustafsson, J.Å., Estrogen receptors and the metabolic network. Cell Metab. 14 (2011), 289–299.
39. [39] Ehrmann, D.A., Polycystic ovary syndrome. N. Engl. J. Med. 352 (2005), 1223–1236.
40. [40] Polotsky, A.J., Allshouse, A., Crawford, S.L., Harlow, S.D., Khalil, N., Santoro, N., Legro, R.S., Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J. Clin. Endocrinol. Metab. 97:20129 (2016), E868–E877.
41. [41] Xita, N., Tsatsoulis, A., Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental clinical, and genetic association studies. J. Clin. Endocrinol. Metab. 91 (2006), 1660–1666.
42. [42] Urbanek, M., The genetics of the polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007), 103–111.
43. [43] Kelly, C.J., Speirs, A., Gould, G.W., Petrie, J.R., Lyall, H., Connell, J.M., Altered vascular function in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 (2002), 742–746.
44. [44] Christian, R.C., Dumesic, D.A., Behrenbeck, T., Oberg, A.L., Sheedy, P.F. 2nd, Fitzpatrick, L.A., Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88 (2003), 2562–2568.
45. [45] Talbott, E.O., Guzick, D.S., Sutton-Tyrrell, K., McHugh-Pemu, K.P., Zborowski, J.V., Remsberg, K.E., Kuller, L.H., Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler. Thromb. Vasc. Biol. 20 (2000), 2414–2421.
46. [46] Sverrisdóttir, Y.B., Mogren, T., Kataoka, J., Janson, P.O., Stener-Victorin, E., Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?. Am. J. Physiol. Endocrinol. Metab. 294 (2008), E576–E581.
47. [47] Yang, R., Yang, S., Li, R., Liu, P., Qiao, J., Zhang, Y., Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reprod. Biol. Endocrinol., 14, 2016, 67.
48. [48] Polotsky, A.J., Allshouse, A., Crawford, S.L., Harlow, S.D., Khalil, N., Santoro, N., Legro, R.S., Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J. Clin. Endocrinol. Metab. 97 (2012), E868–E877.
49. [49] Hwang, W.J., Lee, C.Y., Effect of psychosocial factors on metabolic syndrome in male and female blue-collar workers. Jpn. J. Nurs. Sci. 11 (2014), 23–34.
50. [50] Yang, J.J., Yoon, H.S., Lee, S.A., Choi, J.Y., Song, M., Han, S., Lee, J.K., Kang, D., Metabolic syndrome and sex-specific socio-economic disparities in childhood and adulthood: the Korea National Health and Nutrition Examination Surveys. Diabetes Med. 31 (2014), 1399–1409.
51. [51] Ecob, R., Smith, G.D., Income and health: what is the nature of the relationship. Soc. Sci. Med. 48 (1999), 693–705.
52. [52] Sarlio-Lähteenkorva, S., Lahelma, E., The association of body mass index with social and economic disadvantage in women and men. Int. J. Epidemiol. 28 (1999), 445–449.
53. [53] Jeffery, R.W., Forster, J.L., Folsom, A.R., Luepker, R.V., Jacobs, D.R. Jr, Blackburn, H., The relationship between social status and body mass index in the Minnesota Heart Health Program. Int. J. Obes. 13 (1989), 59–67.
54. [54] Xu, S.H., Qiao, N., Huang, J.J., Sun, C.M., Cui, Y., Tian, S.S., Wang, C., Liu, X.M., Zhang, H.X., Wang, H., Liang, J., Lu, Q., Wang, T., Gender differences in dietary patterns and their association with the prevalence of metabolic syndrome among Chinese: a cross-sectional study. Nutrients, 8, 2016, 180.
55. [55] Hulme, P.A., Walker, S.N., Effle, K.J., Jorgensen, L., McGowan, M.G., Nelson, J.D., Pratt, E.N., Health-promoting lifestyle behaviors of Spanish-speaking Hispanic adults. J. Transcult. Nurs. 14 (2003), 244–254.
56. [56] Beşer, A., Bahar, Z., Büyükkaya, D., Health promoting behaviors and factors related to lifestyle among Turkish workers and occupational health nurses' responsibilities in their health promoting activities. Ind. Health 45 (2007), 151–159.
57. [57] Fonseca, M.J., Gaio, R., Lopes, C., Santos, A.C., Association between dietary patterns and metabolic syndrome in a sample of Portuguese adults. Nutr. J., 11, 2012, 64.
58. [58] Baxter, A.J., Coyne, T., McClintock, C., Dietary patterns and metabolic syndrome–a review of epidemiologic evidence. Asia Pac. J. Clin. Nutr. 15 (2006), 134–142.
59. [59] Deshmukh-Taskar, P.R., O'Neil, C.E., Nicklas, T.A., Yang, S.J., Liu, Y., Gustat, J., Berenson, G.S., Dietary patterns associated with metabolic syndrome: sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr. 12 (2009), 2493–2503.
60. [60] Dallongeville, J., Cottel, D., Ferrières, J., Arveiler, D., Bingham, A., Ruidavets, J.B., Haas, B., Ducimetière, P., Amouyel, P., Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care 28 (2005), 409–415.
61. [61] Vogelzangs, N., Beekman, A.T., Kritchevsky, S.B., Newman, A.B., Pahor, M., Yaffe, K., Rubin, S.M., Harris, T.B., Satterfield, S., Simonsick, E.M., Penninx, B.W., Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007), 563–569.
62. [62] Pyykkönen, A.J., Räikkönen, K., Tuomi, T., Eriksson, J.G., Groop, L., Isomaa, B., Stressful life events and the metabolic syndrome: the prevalence: prediction and prevention of diabetes (PPP)-Botnia Study. Diabetes Care 33 (2010), 378–384.
63. [63] Sans, S., Puigdefábregas, A., Paluzie, G., Monterde, D., Balaguer-Vintró, I., Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study. Eur. Heart J. 26 (2005), 505–515.
64. [64] Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
65. [65] Barrett-Connor, E.L., Cohn, B.A., Wingard, D.L., Edelstein, S.L., Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265 (1991), 627–631.
66. [66] Peters, S.A., Huxley, R.R., Woodward, M., Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57 (2014), 1542–1551.
67. [67] Peters, S.A., Huxley, R.R., Woodward, M., Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts including 775,385 individuals and 12,539 strokes. Lancet 383 (2014), 1973–1980.
68. [68] Haffner, S.M., Miettinen, H., Stern, M.P., Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 40 (1997), 711–717.
69. [69] Onat, A., Ceyhan, K., Başar, O., Erer, B., Toprak, S., Sansoy, V., Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels–a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002), 285–292.
70. [70] Hunt, K.J., Resendez, R.G., Williams, K., Haffner, S.M., Stern, M.P., San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004), 1251–1257.
71. [71] Schillaci, G., Pirro, M., Vaudo, G., Gemelli, F., Marchesi, S., Porcellati, C., Mannarino, E., Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43 (2004), 1817–1822.
72. [72] McNeill, A.M., Rosamond, W.D., Girman, C.J., Golden, S.H., Schmidt, M.I., East, H.E., Ballantyne, C.M., Heiss, G., The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005), 385–390.
73. [73] Song, X., Tabák, A.G., Zethelius, B., Yudkin, J.S., Söderberg, S., Laatikainen, T., Stehouwer, C.D., Dankner, R., Jousilahti, P., Onat, A., Nilsson, P.M., Satman, I., Vaccaro, O., Tuomilehto, J., Qiao, Q., DECODE Study Group, Obesity attenuates gender differences in cardiovascular mortality. Cardiovasc. Diabetol., 13, 2014, 144.
74. [74] Daugherty, S.L., Masoudi, F.A., Zeng, C., Ho, P.M., Margolis, K.L., O'Connor, P.J., Go, A.S., Magid, D.J., Sex differences in cardiovascular outcomes in patients with incident hypertension. J. Hypertens. 31 (2013), 271–277.
75. [75] Wilson, P.W., D'Agostino, R.B., Parise, H., Sullivan, L., Meigs, J.B., Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005), 3066–3072.
76. [76] Najarian, R.M., Sullivan, L.M., Kannel, W.B., Wilson, P.W., D'Agostino, R.B., Wolf, P.A., Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch. Intern. Med. 166 (2006), 106–111.
77. [77] Khang, Y.H., Cho, S.I., Kim, H.R., Risks for cardiovascular disease stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis 213 (2010), 579–585.
78. [78] Wang, W.S., Wahlqvist, M.L., Hsu, C.C., Chang, H.Y., Chang, W.C., Chen, C.C., Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health, 12, 2012, 111.
79. [79] Bassi, N., Karagodin, I., Wang, S., Vassallo, P., Priyanath, A., Massaro, E., Stone, N.J., Lifestyle modification for metabolic syndrome: a systematic review. Am. J. Med. 127:1242 (2014), e1–e10.
80. [80] Yamaoka, K., Tango, T., Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med., 10, 2012, 138.
81. [81] Lin, C.H., Chiang, S.L., Tzeng, W.C., Chiang, L.C., Systematic review of impact of lifestyle-modification programs on metabolic risks and patient-reported outcomes in adults with metabolic syndrome. Worldviews Evid. Based Nurs. 11 (2014), 361–368.
82. [82] Svetkey, L.P., Stevens, V.J., Brantley, P.J., Appel, L.J., Hollis, J.F., Loria, C.M., Vollmer, W.M., Gullion, C.M., Funk, K., Smith, P., Samuel-Hodge, C., Myers, V., Lien, L.F., Laferriere, D., Kennedy, B., Jerome, G.J., Heinith, F., Harsha, D.W., Evans, P., Erlinger, T.P., Dalcin, A.T., Coughlin, J., Charleston, J., Champagne, C.M., Bauck, A., Ard, J.D., Aicher, K., Weight Loss Maintenance Collaborative Research Group, Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 299 (2008), 1139–1148.
83. [83] Wu, Y.T., Hwang, C.L., Chen, C.N., Chuang, L.M., Home-based exercise for middle-aged Chinese at diabetic risk: a randomized controlled trial. Prev. Med. 52 (2011), 337–343.
84. [84] Ma, J., Yank, V., Xiao, L., Lavori, P.W., Wilson, S.R., Rosas, L.G., Stafford, R.S., Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern. Med. 173 (2013), 113–121.
85. [85] Orchard, T.J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., Diabetes Prevention Program Research Group, The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med. 142 (2005), 611–619.
86. [86] Perreault, L., Ma, Y., Dagogo-Jack, S., Horton, E., Marrero, D., Crandall, J., Barrett-Connor, E., Diabetes Prevention Program. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 31 (2008), 1416–1421.
87. [87] Tuomilehto, J., Lindström, J., Eriksson, J.G., Valle, T.T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M., Finnish Diabetes Prevention Study Group, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001), 1343–1350.
88. [88] Vissers, D., Hens, W., Taeymans, J., Baeyens, J.P., Poortmans, J., Van Gaal, L., The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One, 8, 2013, e56415.